keidkeidHome
10-QFiling Date: Apr 22, 2026

Quest Diagnostics (DGX) 10-Q (Apr 22, 2026)

dgx-20260331

View SEC Filing
ACC: 0001022079-26-000043
Key Financial Metrics3M Mar'26 · 2026-03-31
Revenue$2.90B
Net Income$252.0M
Total Assets$16.67B
Stockholders' Equity$10.15B
Operating Cash Flow$278.0M

More filings from Quest Diagnostics (DGX)

  • 10-QQuest Diagnostics (DGX) 10-Q · Jul 23, 2026Quarterly Report · ended 2026-06-30 · Rev $3.0B, NI $320.0M
  • 8-KQuest Diagnostics (DGX) 8-K · Jul 23, 2026Earnings Release; Financial Statements
  • 8-KQuest Diagnostics (DGX) 8-K · May 21, 2026
  • 8-KQuest Diagnostics (DGX) 8-K · May 8, 2026
  • 8-KQuest Diagnostics (DGX) 8-K · May 1, 2026
  • 8-KQuest Diagnostics (DGX) 8-K · Apr 21, 2026

Recent 10-Q filings from other companies

  • 10-QLennar 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $8.0B, NI $283.9M
  • 10-QNike (NKE) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $11.2B, NI $712.0M
  • 10-QDarden Restaurants (DRI) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-30 · Rev $3.2B, NI $233.4M
  • 10-QMccormick & (MKC) 10-Q · Oct 1, 2026Quarterly Report · ended 2026-08-31 · Rev $5.8B, NI $97.6M
  • 10-QConagra Brands (CAG) 10-Q · Sep 30, 2026Quarterly Report · ended 2026-08-30 · Rev $2.6B, NI $174.3M
Q

Quest Diagnostics (DGX)

10-QDGX

Quarterly Report (10-Q)

Filing Date
Apr 22, 2026
Document
dgx-20260331
ACC
0001022079-26-000043
View SEC Filing

keid analysis is for reference only and does not constitute investment advice.